Malta Welcomes New Malaria Treatment for Infants
The WHO approves the first malaria treatment for infants under 6 months, offering hope to Maltese families traveling to endemic regions.
The WHO approves the first malaria treatment for infants under 6 months, offering hope to Maltese families traveling to endemic regions.
Malta’s youngest residents gain protection against malaria with WHO’s approval of DHA-PQ, a game-changer for the island’s health landscape.
Malta celebrates the WHO’s approval of the first-ever malaria treatment for infants, a significant step in the fight against this deadly disease.
The WHO’s approval of a new malaria treatment for infants brings hope to Malta’s fight against the disease, protecting our youngest residents and tourists.